Form 8-K - Current report:
SEC Accession No. 0001102624-17-000078
Filing Date
2017-02-10
Accepted
2017-02-10 08:12:45
Documents
2
Period of Report
2017-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORPORATION 8-K immucell8k.htm 8-K 10545
2 EXHIBIT 99.1 exhibit99.htm EX-99 16552
  Complete submission text file 0001102624-17-000078.txt   28186
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 17589627
SIC: 2835 In Vitro & In Vivo Diagnostic Substances